Vanadate ion inhibits actomyosin interaction in chemically skinned vascular smooth muscle.

J. Peterson

DOI: https://doi.org/10.1016/S0006-291X(80)80114-8

1980-08-29

Abstract:

What problem does this paper attempt to address?

Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.

Jing Shen,Li-Hong Wang,Liang-Rong Zheng,Jian-Hua Zhu,Shen-Jiang Hu

DOI: https://doi.org/10.1177/1074248410373750

2010-01-01

Journal of Cardiovascular Pharmacology and Therapeutics

Abstract:Background: Gap junctions, which serve as intercellular channels that allow the passage of ions and other small molecules between neighboring cells, play an important role in vital functions, including the regulation of cell growth, differentiation, and development. Statins, the 3-hydroxy-3-methylglutaryl-coenzymeA (HMG-CoA) reductase inhibitors, have been shown to inhibit the migration and proliferation of smooth muscle cells (SMCs) leading to an antiproliferative effect. Recent studies have shown that statins can reduce gap junction protein connexin43 (Cx43) expression both in vivo and in vitro. However, little work has been done on the effects of statins on gap junctional intercellular communication (GJIC). We hypothesized in this study that lovastatin inhibits vascular smooth muscle cells (VSMCs) migration through the inhibition of the GJIC. Methods: Rat aortic SMCs (RASMCs) were exposed to lovastatin. Vascular smooth muscle cells migration was then assessed with a Transwell migration assay. Gap junctional intercellular communication was determined by using fluorescence recovery after photobleaching (FRAP) analysis, which was performed with a laser-scanning confocal microscope. Results: The migration of the cultured RASMCs were detected by Trans. well system. Cell migration was dose-dependently inhibited with lovastatin. Compared with that in the control (110 +/- 26), the number of migrated SMCs was significantly reduced to 72 +/- 24 (P < .05), 62 +/- 18 (P < .01), and 58 +/- 19 (P < .01) at the concentration of 0.4, 2, and 10 umol/L, per field. The rate of fluorescence recovery (R) at 5 minutes after photobleaching was adopted as the functional index of GJIC. The R- value of cells exposed to lovastatin 10 umol/L for 48 hours was 24.38% +/- 4.84%, whereas the cells in the control group had an R- value of 36.11% +/- 10.53%, demonstrating that the GJIC of RASMCs was significantly inhibited by lovastatin (P < .01). Smaller concentrations of lovastatin 0.08 umol/L did not change gap junction coupling (P > .05). Conclusions: These results suggest that lovastatin inhibits migration in a dose-dependent manner by attenuating JIC. Suppression of gap junction function could add another explanation of statin-induced antiproliferative effect.
[Relaxant Effect of Astragalus Membranaceus on Smooth Muscle Cells of Rat Thoracic Aorta].

Bi-qi Zhang,Shen-jiang Hu,Qi-xian Shan,Jian Sun,Qiang Xia

DOI: https://doi.org/10.3785/j.issn.1008-9292.2005.01.013

2005-01-01

Abstract:OBJECTIVE:To investigate the effect of Astragalus membranaceus(AM) on vascular circles and the underlying mechanisms.METHODS:The study was performed with the model of isolate rat thoracic aorta rings in organ bath. When the endothelium of rat thoracic aorta was removed,the effect of accumulated AM on aorta rings in resting tension, or pre-constricted with KCl, or pre-constricted with phenylephrine (PE) was observed. And to explove the mechanism, the aorta rings were incubated with Ca(2+)-free medium alone, or Ca(2+)-free medium plus heparin, or propranolol alone before pre-contraction with PE.RESULTS:AM had no significant effects on aorta rings in resting tension or pre-constricted with KCl. When the concentration of AM was cumulated to 10(-1), 3 x 10(-1),10(0), 3 x 10(0) g/L, it caused concentration-dependent relaxation while aorta rings were pre-constricted with PE(3 x 10(-7)mol/L), compared with the control [(90.4 +/-4.2)% compared with (94.7 +/-2.4)%,(86.1 +/-5.0)% compared with (92.6 +/-3.2)%, (82.3 +/-5.9)% compared with (90.4 +/-3.6) %, (78.3 +/-6.0)% compared with (88.1 +/-4.0)%]. This effect was not inhibited by Ca(2+)-free medium or propranolol alone. However, the effect was attenuated by the co-incubation with heparin and Ca(2+)-free medium [without heparin:(76.2+/-4.3)% compared with (92.3 +/-5.9)%, with heparin: (95.3+/-0.5)% compared with (95.1+/-0.6)%].CONCLUSION:The results indicate that AM can relax the rat thoracic aorta rings without endothelium. The mechanism may include the inhibition of intracellular calcium ions release by the 1,4,5-triphosphate inositol-receptor-dependent pathway in vascular smooth muscle cells.
The interaction of vanadyl ions with G-actin

Fang An,BoYan Zhang,BaoWei Chen,Kui Wang

1996-01-01

Abstract:The interaction of VO2+ and G-actin was studied by gel-chromatography, fluorescence and CD spectroscopies, The results revealed that for one G-actin molecule, there is one strong-binding site and several weak-binding sites for VO2+, In low molar ratio of VO2+: G-actin vanadyl ions occupy the strong-binding site at first and cause an increase of alpha-helix content and transformation of the conformation to a more compact one, As the molar ratio increases, vanadyl ions bind to weak-binding sites, but the alpha-helix content decreases and the conformation becomes rather opened. By measuring light-scattering data as the function of time, the kinetics of G-actin association was studied, In a low concentration, the VO2+ ions, like Mg2+, promote the association, but in case of higher concentration, the effect turns to be inhibitive. However, the nature of linear association is not changed.
Exploiting the Cellular Actions of Skca and Ikca Channels to Manipulate Endothelial Function and Vascular Tone

Andrew P. Braun,Jianzhong Sheng,Srikanth Ella,Michael J. Davis,Michael A. Hill

DOI: https://doi.org/10.1096/fasebj.23.1_supplement.627.6

2009-01-01

Abstract:Growing evidence indicates that small‐ and intermediate‐conductance, Ca2+‐activated K+ channels (SKCa and IKCa channels, respectively) play pivotal roles in the cellular mechanisms contributing to stimulated vasorelaxation (i.e. nitric oxide (NO) synthesis, actions of EDHF). Using single cell patch clamp and fluorimetry, along with arteriolar pressure myography, we have obtained novel results demonstrating that activators of SKCa and IKCa channels (i.e. NS309 and DCEBIO, 0.01 ‐ 1 μM) enhance a number of cellular processes associated with stimulated vasorelaxation (i.e. cytosolic Ca2+ elevations, membrane hyperpolarization and NO synthesis). These observed effects of NS309 and DCEBIO were largely prevented by the SKCa and IKCa channel blockers apamin and TRAM‐34 in combination, but not when applied separately. In rat cremaster arterioles pressurized to 70 mmHg, NS309 and DCEBIO reduced myogenic tone and further augmented ACh‐induced vasodilation. The eNOS inhibitor L‐NAME (0.1 mM) decreased ACh‐evoked inhibition of myogenic tone, but did not affect the dilatory responses to NS309 and DCEBIO. The observed inhibition of NS309/DCEBIO action following endothelial denudation confirmed that these agents acted predominantly via the vascular endothelium. Finally, we will discuss initial efforts to discern the contribution of STIM1 to SKCa and IKCa activity and endothelial vasodilatory processes.
AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury

Joshua D. Stone,Avinash Narine,Patti R. Shaver,Jonathan C. Fox,Jackson R. Vuncannon,David A. Tulis

DOI: https://doi.org/10.1152/ajpheart.00446.2012

2013-02-01

Abstract:Vascular smooth muscle cell (VSMC) activation promotes a synthetic phenotype that underlies many vessel growth disorders. In this regard it has been suggested that the metabolic sensor adenosine 5′-monophosphate-activated protein kinase (AMPK) has significant antigrowth and antimetastatic properties and may serve as a viable therapeutic target. In the current study we hypothesized that AMPK reduces neointima formation following balloon injury and that this occurs through reduction in VSMC proliferation and migration. Data reveal that local or systemic dosing with the AMPK agonist 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) significantly increased AMPK activity in vivo and inhibited neointima formation in rat carotid arteries 2 wk after injury. In primary VSMCs, AICAR inhibited migration and induced cytostatic growth arrest through increased protein phosphatase 2A-mediated inhibition of mitosis-promoting cyclin B. AICAR also significantly enhanced AMPK-specific T278 phosphorylation of the actin anticapping vasodilator-activated serum phosphoprotein, increased G- to F-actin ratios and stress fiber formation, and abrogated PDGF-stimulated S397 autophosphorylation of focal adhesion kinase, promigratory cytoplasmic accumulation of paxillin, and extracellular matrix proteolysis by matrix metalloproteinase-9. Together, these results provide compelling evidence that AMPK serves to inhibit vascular smooth muscle migration and proliferation through regulation of cytoskeletal/focal adhesion/ECM stability, increasing our knowledge of this important metabolic regulator and providing support for its continued investigation in the treatment of vascular growth disorders.

cardiac & cardiovascular systems,peripheral vascular disease,physiology
Mechanistic analysis of actin-binding compounds that affect the kinetics of cardiac myosin-actin interaction

Osha Roopnarine,David D Thomas

DOI: https://doi.org/10.1016/j.jbc.2021.100471

Abstract:Actin-myosin mediated contractile forces are crucial for many cellular functions, including cell motility, cytokinesis, and muscle contraction. We determined the effects of ten actin-binding compounds on the interaction of cardiac myosin subfragment 1 (S1) with pyrene-labeled F-actin (PFA). These compounds, previously identified from a small-molecule high-throughput screen (HTS), perturb the structural dynamics of actin and the steady-state actin-activated myosin ATPase activity. However, the mechanisms underpinning these perturbations remain unclear. Here we further characterize them by measuring their effects on PFA fluorescence, which is decreased specifically by the strong binding of myosin to actin. We measured these effects under equilibrium and steady-state conditions, and under transient conditions, in stopped-flow experiments following addition of ATP to S1-bound PFA. We observed that these compounds affect early steps of the myosin ATPase cycle to different extents. They increased the association equilibrium constant K1 for the formation of the strongly bound collision complex, indicating increased ATP affinity for actin-bound myosin, and decreased the rate constant k+2 for subsequent isomerization to the weakly bound ternary complex, thus slowing the strong-to-weak transition that actin-myosin interaction undergoes early in the ATPase cycle. The compounds' effects on actin structure allosterically inhibit the kinetics of the actin-myosin interaction in ways that may be desirable for treatment of hypercontractile forms of cardiomyopathy. This work helps to elucidate the mechanisms of action for these compounds, several of which are currently used therapeutically, and sets the stage for future HTS campaigns that aim to discover new drugs for treatment of heart failure.
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances

Grzegorz Kazek,Monika Głuch-Lutwin,Barbara Mordyl,Elżbieta Menaszek,Monika Kubacka,Anna Jurowska,Dariusz Cież,Bartosz Trzewik,Janusz Szklarzewicz,Monika A. Papież

DOI: https://doi.org/10.3390/ph17020229

IF: 4.6

2024-02-10

Pharmaceuticals

Abstract:In the text, the synthesis and characteristics of the novel ONS-type vanadium (V) complexes with thioanilide derivatives of amino acids are described. They showed the inhibition of human protein tyrosine phosphatases (PTP1B, LAR, SHP1, and SHP2) in the submicromolar range, as well as the inhibition of non-tyrosine phosphatases (CDC25A and PPA2) similar to bis(maltolato)oxidovanadium(IV) (BMOV). The ONS complexes increased [14C]-deoxy-D-glucose transport into C2C12 myocytes, and one of them, VC070, also enhanced this transport in 3T3-L1 adipocytes. These complexes inhibited gluconeogenesis in hepatocytes HepG2, but none of them decreased lipid accumulation in the non-alcoholic fatty liver disease model using the same cells. Compared to the tested ONO-type vanadium complexes with 5-bromosalicylaldehyde and substituted benzhydrazides as Schiff base ligand components, the ONS complexes revealed stronger inhibition of protein tyrosine phosphatases, but the ONO complexes showed greater activity in the cell models in general. Moreover, the majority of the active complexes from both groups showed better effects than VOSO4 and BMOV. Complexes from both groups activated AKT and ERK signaling pathways in hepatocytes to a comparable extent. One of the ONO complexes, VC068, showed activity in all of the above models, including also glucose utilizatiand ONO Complexes are Inhibitors ofon in the myocytes and glucose transport in insulin-resistant hepatocytes. The discussion section explicates the results within the wider scope of the knowledge about vanadium complexes.

pharmacology & pharmacy,chemistry, medicinal
Actin-binding compounds that affect the kinetics of the interaction of cardiac myosin with actin

Osha Roopnarine,David D. Thomas

DOI: https://doi.org/10.1101/2020.09.16.300517

2020-09-17

Abstract:Abstract We measured the effects of ten actin-binding compounds on the interaction of cardiac myosin subfragment 1 (S1) with pyrene labeled F-actin (PFA). These compounds, previously identified from a small-molecule high-throughput screen (HTS), perturb the microsecond structural dynamics of actin and the steady-state activity of actin-activated myosin ATPase. In the present study, we have further characterized their mechanisms of action by measuring their effects on PFA fluorescence, which is decreased specifically by the strong binding of myosin to actin, and is restored upon release of S1 by MgATP. We measured the effects of compounds under equilibrium and steady-state conditions, as affected by S1 and ATP, and also under transient conditions, in stopped-flow experiments following rapid addition of ATP to S1-bound PFA. We observe that these compounds affect the early steps of the myosin ATPase cycle to different extents (mild, moderate, and severe). The compounds decrease the equilibrium constant for the formation of the collision complex and the rate constant for subsequent isomerization to the ternary complex, indicating increased ATP affinity and trapping of ATP in the myosin active site. These compound effects on actin structure inhibit the kinetics of the actin-myosin interaction in ways that may be desirable for possible treatment of hypercontractile forms of hypertrophic cardiomyopathy (HCM). This work helps to elucidate the mechanisms of action of these compounds, several of which are currently used therapeutically, and it sets the stage for future HTS campaigns on a larger scale, to discover new drugs for treatment of heart failure.
Inhibition of mouse neuromuscular transmission and contractile function by okadaic acid and cantharidin

S J Hong

DOI: https://doi.org/10.1038/sj.bjp.0703418

IF: 7.3

2000-07-01

British Journal of Pharmacology

Abstract:Phosphorylations of cellular proteins modulate biological activities. The effects of okadaic acid (0.1–10 μM) and cantharidin (1–100 μM), inhibitors of protein phosphatases, on the synaptic transmission at the mouse neuromuscular junction were explored. Both inhibitors almost completely depressed twitch forces elicited by electrical stimulation of diaphragm muscles (the IC50s for okadaic acid and cantharidin were 1.1±0.2 and 13±1 μM, n=5, respectively) and suppressed contractures evoked by high K+ and ryanodine more than 70%. Contractures caused by cardiotoxin, which destroys the integrity of sarcolemma, were not depressed. Both okadaic acid (10 μM) and cantharidin (100 μM) depolarized muscle membranes from ∼−80 to ∼−60 mV in a partially reversible and tetrodotoxin‐sensitive manner. The initial short‐term enhancement of twitch responses (up to ∼40%) was correlated with the inhibitors‐induced repetitive firings of muscle action potential. Treatment with either agent resulted in nearly complete inhibitions of endplate potential (epp). The IC50s were 0.8±0.2 and 9±2 μM (n=5), respectively, for okadaic acid and cantharidin. On high frequency stimulation, the coefficient of epps was increased more than 10 fold and the extent of epp run‐down during stimulations intensified from ∼25 to ∼75%. Analyses of presynaptic quantal releases revealed decreases in epp quantal content and the immediately available vesicle pool. The frequency of miniature epp was initially elevated up to 2 fold then suppressed down to ∼30%. The small reduction in the amplitude was antagonized when the membrane of endplate area was repolarized. The data suggest that okadaic acid and cantharidin inhibit mobilizations of synaptic vesicles and depress Ca2+ release from sarcoplasmic reticulum and that protein phosphatases participate in the modulation of motor function. British Journal of Pharmacology (2000) 130, 1211–1218; doi:10.1038/sj.bjp.0703418

pharmacology & pharmacy
The effect of a thiadiazinone derived Ca2+ sensitizer on the responsiveness of Mg(2+)-ATPase to Ca2+ in myofibrils isolated from stunned and nonstunned porcine and human myocardium

K Bezstarosti,L K Soei,R Krams,F J Ten Cate,P D Verdouw,J M Lamers

DOI: https://doi.org/10.1016/0006-2952(96)00083-4

1996-05-03

Abstract:Previously, we showed, in an in situ porcine model, that the thiadiazinone derivative [+]EMD 60263, a putative Ca2+ sensitizer with minimal phosphodiesterase III inhibitory properties, increased contractility more profoundly in stunned than in nonstunned myocardium. The aim of the present investigation was to study the mechanism of action by determining the in vitro effects of [+]EMD 60263 on the Ca2+ responsiveness of the Mg(2+)-dependent ATPases of myofibrils and sarcoplasmic reticulum membrane vesicles, isolated from normal ventricle of swine and hypertrophic septum of cardiomyopathic patients. Contamination of the myofibrils with sarcoplasmic reticulum membranes was excluded by testing the effect of the sarcoplasmic reticulum Ca(2+)-pumping ATPase inhibitor thapsigargin. The plasma concentrations at which [+]EMD 60263 exerted its inotropic effect in the in situ porcine model were found to be submicromolar. [+]EMD 60263 stimulated concentration-dependently (1-10 microM) the submaximally activated Mg(2+)-ATPases (at pCa 6.1) of pig heart myofibrils. [+]EMD 60263 (10 microM) shifted the pCa50 of porcine myofibrillar Ca(2+)-stimulated, Mg(2+)-dependent ATPase from 6.00 +/- 0.05 to 6.67 +/- 0.05, whereas the [-]enantiomer EMD 60264 had no significant effect. Although the effect was much less at 1 and 3 microM, [+]EMD 60263 (10 microM) also stimulated maximal myofibrillar Mg(2+)-ATPase activity. The Hill coefficient, reflecting the steepness of the fitted pCa/Mg(2+)-ATPase curve at half-maximal activation, was not affected by [+]EMD 60263 (10 microM). [+]EMD 60263 (10 microM) had no effect on sarcoplasmic reticulum Ca(2+)-stimulated, Mg(2+)-dependent ATPase from swine heart. The thiadiazinone derivative [+]EMD 57033 (10 microM), but not its [-]enantiomer EMD 57439, had similar, although less potent, effects on pig heart myofibrillar Mg(2+)-ATPase activity as compared to [+]EMD 60263. [+]EMD 60263 (3 microM) produced a significantly larger leftward shift of the pCa2+/Mg(2+)-ATPase activity curve of myofibrils isolated from the stunned compared to the adjacent nonstunned myocardium (Delta pCa50s caused by the presence of [+]EMD 60263 amounted to +0.57 +/- 0.04 and +0.42 +/- 0.05, respectively) in the in situ porcine model. The effects of [+]EMD 60263 on myofibrillar Mg(2+)-ATPase of hypertrophic human heart were identical to those observed with porcine heart myofibrils. The results indicate that the positive inotropic action of [+]EMD 60263 observed in the in situ porcine model of stunned myocardium may be primarily due to myofilament sensitization to Ca2+, and that this compound may have a similar action on diseased human myocardium.
Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization

WanHua Lei,HuiXue Liu,LiJun Zhong,XiaoDa Yang,Kui Wang

DOI: https://doi.org/10.1007/s11434-007-0380-0

2007-01-01

Chinese Science Bulletin

Abstract:Several vanadium compounds have been known for the hypoglycemic and anticancer effects. However, the mechanisms of the pharmacological and toxicological effects were not clear. In this work, we investigated the potential targets of vanadium in mitochondria. Vanadyl ions were found to bind to mitochondria from rat liver with a stoichiometry of 244±58 nmol/mg protein and an apparent dissociation constant ( K d ) of (2.0±0.8)×10 −16 mol/L. Using size exclusion chromatography, a vanadium-binding protein was isolated and identified to be the 60-kDa heat shock protein (HSP60) by mass spectrometry analysis and immunoassays. Additionally, binding of vanadyl ions was found to result in depolymerization of homo-oligomeric HSP60 (GroEL). HSP60 is an indispensable molecular chaperone and involved in many kinds of pathogenesis of inflammatory and autoimmune diseases, e.g. type 1 diabetes. Our results suggested that HSP60 could be a novel important target involved in the biological and/or toxicological effects of vanadium compounds.
Chemical, biochemical, and biological behaviors of vanadate and its oligomers.

Xiao-Gai Yang,Kui Wang

DOI: https://doi.org/10.1007/978-3-642-41004-8_1

2013-01-01

Abstract:Vanadate is widely used as an inhibitor of protein tyrosine phosphatases (PTPase) and is routinely applied in cell lysis buffers or immunoprecipitations of phosphotyrosyl proteins. Additionally, vanadate has been extensively studied for its antidiabetic and anticancer effects. In most studies, orthovanadate or metavanadate was used as the starting compound, whereas these "vanadate" solutions may contain more or less oligomerized species. Whether and how different species of vanadium compounds formed in the biological media exert specific biological effect is still a mystery. In the present commentary, we focus on the chemical, biochemical, and biological behaviors of vanadate. On the basis of species formation of vanadate in chemical and biological systems, we compared the biological effects and working mechanism of monovanadate with that of its oligomers, especially the decamer. We propose that different oligomers may exert a specific biological effect, which depends on their structures and the context of the cell types, by different modes of action.
Experimental and Theoretical Insights of Functionalized Hexavanadates on Na+/K+-ATPase Activity; Molecular Interaction Field, Ab Initio Calculations and in Vitro Assays.

Nada Bosnjakovic-Pavlovic,Xiao Xu,Danijela Krstic,Jean-Michel Gilleta,Yongge Wei,Pingfan Wu,Mirjana Colovic,Anne Spasojevic-de Bire

DOI: https://doi.org/10.1016/j.jinorgbio.2019.110720

IF: 4.336

2019-01-01

Journal of Inorganic Biochemistry

Abstract:The influence of three functionalized hexavanadates (V-6): Na-2 [V6O13{(OCH2)(3)CCH3}(2)], [H-2](2) [V6O13{(OCH2)(3)CCH2OCOCH2CH3}(2)] and [(C4H9)(4)N](2) [V6O13{(OCH2)(3)CCH2OOC(CH3)(2)-COOH}(2) on Na+/K+-ATPase activity, was investigated in vitro. Including compounds already tested by Xu et al. (Journal of Inorganic Biochemistry 161 (2016) 27-36), all functionalized hexavanadates inhibit the activity of Na+/K+-ATPase in a dose-dependent manner but with different inhibitory potencies. Na-2 [V6O13{(OCH2)(3)CCH3}(2)] was found to have the best inhibition properties - showing 50% inhibition IC50 = 5.50 x 10(-4) M, while [(C4H9)(4)N](2) [V6O13{(OCH2)(3)CCH2OOC(CH3)(2)-COOH}(2)] showed the lowest inhibitory power, IC50 = 1.31 x 10(-4)M. In order to understand the bioactivity of functionalized hexavanadates series, we have also used a combined theoretical approach: determination of electrostatic potential from ab initio theoretical calculations and computation of the molecular interaction field (MIF) surface.
A Kinetic Model, for the Effects of Vanadate on Human Erythrocyte Membrane

Tianlan Zhang,Kui Wang

DOI: https://doi.org/10.1007/bf02874278

1999-01-01

Science in China Series B Chemistry

Abstract:The effects of vanadate on human erythrocyte membrane have been investigated with stopped-flow and equilibrium fluorescence quenching techniques. The equilibrium study showed a half-quenching concentration(K 1/2 ) of 0.27 mmol.L-1. The stopped-flow experiment exhibited a fast rise (tsk1/f1 S) and a slow drop (tin 1~2 min) in fluorescence. Based on the results and that from the across membrane transport of vanadate, a kinetic model is proposed which suggests that the membrane proteins experience a series of conformational changes before and during the quenching of the intrinsic fluorescence. These changes are induced mainly by three kinds of interactions: (i) the long-distance, non-specific interaction between the vanadate and the erythrocyte membrane surface, (ii) the charge interaction between the vanadate and parts of the membrane proteins, and(iii) the binding of the vanadate to some membrane proteins.
Binding of vanadate to human erythrocyte ghosts and subsequent events

Boyan Zhang,Li Ruan,Baowei Chen,Jinfen Lu,Kui Wang

DOI: https://doi.org/10.1023/A:1018324416694

1997-01-01

BioMetals

Abstract:Spectroscopic techniques were used to investigate the interaction between vanadate and human erythrocyte ghosts. Direct evidence from 51 V nuclear magnetic resonance (NMR) studies suggested that the monomeric and polymeric vanadate species may bind to the anion binding sites of band 3 protein of the erythrocyte membrane. The results of 51 V NMR studies and the quenching effect of vanadate on the intrinsic fluorescence of the membrane proteins indicated that in the low concentration range of vanadate (<0.6 mm), monomeric vanadate binds mostly to the anion sites of band 3 protein with the dissociation constant close to 0.23 mm. The experiments of sulfhydryl content titration by the method of Ellman and residue sulfhydryl-labeled fluorescence spectroscopies clearly displayed that vanadate reacts directly with sulfhydryl groups. The appearance of the anisotropic election spin resonance (ESR) signal of vanadyl suggests that a small (c. 3%) amount of vanadate was reduced by sulfhydryl groups of membrane proteins. The fluidity and order of intact ghost membrane were reduced by the reaction with vanadate, as shown by the ESR studies employing the protein- and lipid-specific spin labels. It was concluded that although vanadates mainly bind to band 3 protein, a minor part of vanadate may oxidize the residue sulfhydryl groups of membrane proteins, and thus decrease the fluidity of erythrocyte membrane.
Abstract 5077: Inhibition of Smooth Muscle Myosin, a Novel Anti-Hypertensive Strategy

You‐Tang Shen,Li Chen,Xin Zhao,Xiangping Qian,David J. Morgans,Stephen F. Vatner,Fady I. Malik

DOI: https://doi.org/10.1161/circ.120.suppl_18.s1044-d

IF: 37.8

2009-01-01

Circulation

Abstract:Inhibition of smooth muscle myosin is a novel mechanism to reduce vascular smooth muscle tone and may represent a new antihypertensive class. The goal of this study was to examine the effects of a smooth muscle myosin inhibitor, CK-2018448 (CK-448), in conscious dogs at baseline and in the hypertensive state. Hypertension was induced by wrapping one kidney combined with renal artery stenosis in 5 dogs instrumented with a left ventricular (LV) pressure gauge, Transonic flow probes on the ascending aorta, coronary, renal and iliac arteries, and pressure catheters in the aorta and left atrium. One week after surgery, when the dogs were still normotensive, CK-448 (2– 6 mg/kg, iv bolus) produced dose-dependent decreases in mean arterial pressure (MAP) and total peripheral vascular resistance (TPR) and increases in cardiac output, LV dP/dt and heart rate; the latter were nearly eliminated by autonomic blockade. The changes in TPR and regional vascular resistance after administration of CK-448 (6 mg/kg, iv) were compared with those of the calcium channel blocker, amlodipine (0.5 mg/kg, iv) at doses inducing similar reductions in TPR (Table ). The pattern of regional vasodilation in the kidney and limb was different for the 2 drugs; the greatest vasodilation for amlodipine was in the limb, whereas for CK-448 it was the kidney. When hypertension developed 2– 4 weeks later, baseline MAP rose from 101±4 to 158±7 mmHg and TPR from 27±3 to 100±10 mmHg/L/min. The effect of CK-448 on TPR was more than in the normotensive state and there was a similar preferential renal vasodilation with CK-448, i.e., it increased renal blood flow by 76% (t = 3 min), which was twice the increase in the iliac bed. Thus, the smooth muscle myosin inhibitor and a calcium channel blocker elicited different patterns of regional vasodilation. The renal vasodilation induced by CK-448 could have additional salutary effects in hypertension, which is often accompanied by renal insufficiency.
Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle

M Tajimi,H Ozaki,K Sato,H Karaki

DOI: https://doi.org/10.1007/BF00170659

Abstract:1. The effects of a novel cyclic AMP phosphodiesterase inhibitor, E-1020 (1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate), on cytosolic Ca++ level ([Ca++]cyt) and muscle tension were examined in rat aorta using a fluorescent Ca++ indicator, fura-2. 2. The sustained contraction induced by norepinephrine was more strongly inhibited by E-1020 than that induced by high K+. The contraction induced by a higher concentration of the stimulant was less sensitive to E-1020 than that due to a lower concentration. 3. Contractions induced by high K+ and norepinephrine followed the increase in [Ca++]cyt. E-1020 inhibited the increments in [Ca++]cyt and muscle tension. A Ca++ channel blocker, verapamil, inhibited the norepinephrine-stimulated [Ca++]cyt more strongly than the contraction. E-1020 inhibited the verapamil-insensitive portion of the norepinephrine-stimulated [Ca++]cyt and contraction. 4. Norepinephrine transiently increased [Ca++]cyt and muscle tension in Ca(++)-free solution. E-1020 inhibited the transient contraction but not the stimulated [Ca++]cyt. 5. E-1020 increased the cyclic AMP content of the muscle. The effects of E-1020 on cyclic AMP content and contraction were potentiated by an activator of adenylate cyclase, forskolin. 6. These results suggest that E-1020 inhibits the vascular contractility by the decrease in [Ca++]cyt and decrease in Ca++ sensitivity of contractile elements. These effects may be mediated by the increase in cyclic AMP content of the muscle.
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells

P. M. Mohan,Ziya Gokslan,W. Yung,P. Steck,A. Kyritsis,B. Aggarwal,J. Uhm,S. Mohanam,S. Chintala,Raymond Sawaya,J. S. Rao

DOI: https://doi.org/10.1002/(SICI)1098-2744(199912)26:4<274::AID-MC6>3.0.CO;2-1

1999-12-01

Molecular Carcinogenesis

Abstract:Cell‐matrix interactions exert a profound influence on cell function and behavior. Our earlier observations suggested that disruption of the actin cytoskeleton results in the inhibition of phorbol ester–induced matrix metalloproteinase (MMP)‐9 expression. In this study, to understand the role of protein tyrosine phosphatases in matrix metalloproteinase‐9 expression, we treated glioblastoma cells with vanadate and phenylarsine oxide (PAO), which are inhibitors of protein tyrosine phosphatases. Vanadate and PAO inhibited expression of phorbol ester–induced MMP‐9 as well as constitutive expression of matrix metalloproteinase‐2 in a dose‐ and time‐dependent fashion. An assay of the activity of phosphotyrosine phosphatase (PTPase) indicated that vanadate‐treated cells had reduced PTPase activity compared with that of untreated controls. Vanadate and PAO also inhibited actin polymerization, cell spreading, migration, and invasion of glioma cells. Furthermore, elevated levels of protein tyrosine phosphorylation were observed in vanadate‐ and PAO‐treated cells in both a concentration‐ and time‐dependent fashion and were seen to have an inverse correlation with focal adhesion kinase protein expression. These results suggest that vanadate and PAO inhibited migration and invasion of glioma cells by their effect on the cytoskeleton and inhibition of MMP expression. Mol. Carcinog. 26:274–285, 1999. © 1999 Wiley‐Liss, Inc.

Medicine,Biology
Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination

Astrid Trion,Cindy Schutte-Bart,Wilhelmina H. Bax,J. Wouter Jukema,Arnoud van der Laarse

DOI: https://doi.org/10.1007/s11010-007-9608-1

IF: 3.842

2007-10-02

Molecular and Cellular Biochemistry

Abstract:Background Vascular calcification is an organized process in which vascular smooth muscle cells (VSMCs) are implicated primarily. The purpose of the present study was to assess the effects of calcium antagonists and statins on VSMC calcification in vitro. Methods VSMC calcification was stimulated by incubation in growth medium supplemented with 10 mmol/l β-glycerophosphate, 8 mmol/l CaCl2, 10 mmol/l sodium pyruvate, 1 μmol/l insulin, 50 μg/ml ascorbic acid, and 100 nmol/l dexamethasone (calcification medium). Calcification, proliferation, and apoptosis of VSMCs were quantified. Results Calcium deposition was stimulated dose-dependently by β-glycerophosphate, CaCl2, and ascorbic acid (all P < 0.01). Addition of amlodipine (0.01–1 μmol/l) to the calcification medium did not affect VSMC calcification. However, atorvastatin (2–50 μmol/l) stimulated calcium deposition dose-dependently. Combining treatments stimulated calcification to a degree similar to that observed with atorvastatin alone. Both atorvastatin and amlodipine inhibited VSMC proliferation at the highest concentration used. Only atorvastatin (50 μmol/l) induced considerable apoptosis of VSMCs. Conclusion In vitro calcification of VSMCs is not affected by amlodipine, but is stimulated by atorvastatin at concentrations ≥10 μmol/l, which could contribute to the plaque-stabilizing effect reported for statins.

cell biology
A Combined Crystallographic Analysis and Ab Initio Calculations to Interpret the Reactivity of Functionalized Hexavanadates and Their Inhibitor Potency Toward Na+/K+-ATPase

Xiao Xu,Nada Bosnjakovic-Pavlovic,Mirjana B. Colovic,Danijela Z. Krstic,Vesna M. Vasic,Jean-Michel Gillet,Pingfan Wu,Yongge Wei,Anne Spasojevic-de Bire

DOI: https://doi.org/10.1016/j.jinorgbio.2016.04.029

IF: 4.336

2016-01-01

Journal of Inorganic Biochemistry

Abstract:In vitro influence of five synthesized functionalized hexavanadates (V6) on commercial porcine cerebral cortex Na+/K+-ATPase activity has been studied. Dose dependent Na+/K+-ATPase inhibition was obtained for all investigated compounds. Calculated half maximal inhibitory concentration IC50 values, in mol/L, for Na+/K+-ATPase were 7.6×10−5, 1.8×10−5, 2.9×10−5, 5.5×10−5 for functionalized hexavanadates (V6) with tetrabutylammonium (TBA) [V6–CH3][TBA]2, [V6–NO2][TBA]2, [V6–OH][TBA]2 and [V6–C3][TBA]2 respectively. [V6–OH][Na]2 inhibited Na+/K+-ATPase activity up to 30% at maximal investigated concentration 1×10−3mol/L. This reactivity has been interpreted using a study of the non-covalent interactions of functionalized hexavanadate hybrids through Cambridge Structural Database (CSD) analysis. Bibliographic searching has led to 18 different structures and 99 contacts. We have observed that C–H⋯O contacts consolidate the structures. We have also performed density functional theory (DFT) calculations and have determined electrostatic potential values at the molecular surface on a series of functionalized V6. These results enlightened their chemical reactivity and their potential biological applications such as the inhibition of the ATPase.

Vanadate ion inhibits actomyosin interaction in chemically skinned vascular smooth muscle.

Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.

[Relaxant Effect of Astragalus Membranaceus on Smooth Muscle Cells of Rat Thoracic Aorta].

The interaction of vanadyl ions with G-actin

Exploiting the Cellular Actions of Skca and Ikca Channels to Manipulate Endothelial Function and Vascular Tone

AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury

Mechanistic analysis of actin-binding compounds that affect the kinetics of cardiac myosin-actin interaction

Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances

Actin-binding compounds that affect the kinetics of the interaction of cardiac myosin with actin

Inhibition of mouse neuromuscular transmission and contractile function by okadaic acid and cantharidin

The effect of a thiadiazinone derived Ca2+ sensitizer on the responsiveness of Mg(2+)-ATPase to Ca2+ in myofibrils isolated from stunned and nonstunned porcine and human myocardium

Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization

Chemical, biochemical, and biological behaviors of vanadate and its oligomers.

Experimental and Theoretical Insights of Functionalized Hexavanadates on Na+/K+-ATPase Activity; Molecular Interaction Field, Ab Initio Calculations and in Vitro Assays.

A Kinetic Model, for the Effects of Vanadate on Human Erythrocyte Membrane

Binding of vanadate to human erythrocyte ghosts and subsequent events

Abstract 5077: Inhibition of Smooth Muscle Myosin, a Novel Anti-Hypertensive Strategy

Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle

Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells

Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination

A Combined Crystallographic Analysis and Ab Initio Calculations to Interpret the Reactivity of Functionalized Hexavanadates and Their Inhibitor Potency Toward Na+/K+-ATPase